Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Regulation, FDA Oncology

Gideon M. Blumenthal

MD

🏢US Food and Drug Administration (historical); Merck🌐USA

Former Deputy Division Director, Division of Oncology Products

50
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Gideon Blumenthal previously served in senior FDA oncology roles and contributed to the review of many targeted therapy approvals in lung cancer. He has co-authored influential analyses of trial endpoints and regulatory frameworks. His work has shaped contemporary oncology drug review standards.

Share:

🧪Research Fields 研究领域

oncology regulation
lung cancer
targeted therapy review
FDA guidance
drug approval

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Gideon M. Blumenthal 的研究动态

Follow Gideon M. Blumenthal's research updates

留下邮箱,当我们发布与 Gideon M. Blumenthal(US Food and Drug Administration (historical); Merck)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment